We have located links that may give you full text access.
Pharmacological Treatment of Patients with Paraphilic Disorders and Risk of Sexual Offending: An International Perspective.
World Journal of Biological Psychiatry 2017 October 24
OBJECTIVES: The present study aims to evaluate existing policy and practice relating to the use of pharmacological treatments with patients suffering from paraphilic disorders who are at risk of committing further sexual offences.
METHODS: A systematic literature search was conducted to document current legal policies across 26 different countries. Additionally, a questionnaire assessing the practice of pharmacological treatment was sent to practitioners involved in the treatment of patients with paraphilic disorders.
RESULTS: Legal policies concerning the preconditions of using pharmacological treatments differ considerably between countries and for most jurisdictions do not exist. Drawing on the responses of 178 practitioners, pharmacological agents are a useful addition to psychotherapeutic interventions, especially with those patients classified as medium to high risk for sexually violent behaviours. It would appear that most patients are medically examined, are informed of the risks and possible side effects before treatment commences and are also obliged to sign a consent form.
CONCLUSIONS: Although pharmacological agents can be seen as an intrusion into a patients' sexual self-determination, results indicate that ethical and clinical standards are being met in the majority of cases. However, further promotion of current WFSBP-treatment guidelines would help to standardize practice across North American and European countries.
METHODS: A systematic literature search was conducted to document current legal policies across 26 different countries. Additionally, a questionnaire assessing the practice of pharmacological treatment was sent to practitioners involved in the treatment of patients with paraphilic disorders.
RESULTS: Legal policies concerning the preconditions of using pharmacological treatments differ considerably between countries and for most jurisdictions do not exist. Drawing on the responses of 178 practitioners, pharmacological agents are a useful addition to psychotherapeutic interventions, especially with those patients classified as medium to high risk for sexually violent behaviours. It would appear that most patients are medically examined, are informed of the risks and possible side effects before treatment commences and are also obliged to sign a consent form.
CONCLUSIONS: Although pharmacological agents can be seen as an intrusion into a patients' sexual self-determination, results indicate that ethical and clinical standards are being met in the majority of cases. However, further promotion of current WFSBP-treatment guidelines would help to standardize practice across North American and European countries.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app